These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 880710)

  • 1. Intestinal absorption aspect of non-lipophilic low molecular weight drugs: a case of cephalexin and cefazolin.
    Yasuhara M; Miyoshi Y; Yuasa A; Kimura T; Muranishi S
    Chem Pharm Bull (Tokyo); 1977 Apr; 25(4):675-9. PubMed ID: 880710
    [No Abstract]   [Full Text] [Related]  

  • 2. Cefazolin and cephalexin levels in prostatic tissue and sera.
    Litvak AS; Franks CD; Vaught SK; McRoberts JW
    Urology; 1976 May; 7(5):497-9. PubMed ID: 1274008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of cephalosporin antibiotics.
    Brogard JM; Comte F; Pinget M
    Antibiot Chemother (1971); 1978; 25():123-62. PubMed ID: 352251
    [No Abstract]   [Full Text] [Related]  

  • 4. Cefatrizine (SK&F 60771), a new oral cephalosporin: serum levels and urinary recovery in humans after oral or intramuscular administration--comparative study with cephalexin and cefazolin.
    Actor P; Pitkin DH; Lucyszyn G; Weisbach JA; Bran JL
    Antimicrob Agents Chemother; 1976 May; 9(5):800-3. PubMed ID: 949177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of the new cephalosporins.
    Brogard JM; Comte F
    Antibiot Chemother (1971); 1982; 31():145-210. PubMed ID: 6277241
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of absorption and excretion of cefazolin with cephalothin and cephapirin.
    Shimizu T
    Jpn J Antibiot; 1975 Aug; 28(4):542-8. PubMed ID: 1160145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3-Deacetoxy-7-(alpha-amino-1-cyclohexenylacetamido) cephalosporanic acid (SCE-100), a new semisynthetic cephalosporin. III. Comparative studies on absorption, distribution and excretion of SCE-100 and cephalexin (CEX) in laboratory animals.
    Yamazaki T; Tsuchiya K
    J Antibiot (Tokyo); 1976 May; 29(5):571-8. PubMed ID: 956046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human serum protein binding of cephalosporin antibiotics in vitro.
    Singhvi SM; Heald AF; Gadebusch HH; Resnick ME; Difazio LT; Leitz MA
    J Lab Clin Med; 1977 Feb; 89(2):414-20. PubMed ID: 833477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neural modulation of cephalexin intestinal absorption through the di- and tripeptide brush border transporter of rat jejunum in vivo.
    Berlioz F; Julien S; Tsocas A; Chariot J; Carbon C; Farinotti R; Rozé C
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1037-44. PubMed ID: 10027841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Saturable absorption of amino-cephalosporins by the rat intestine.
    Tsuji A; Nakashima E; Asano T; Nakashima R; Yamana T
    J Pharm Pharmacol; 1979 Oct; 31(10):718-20. PubMed ID: 41054
    [No Abstract]   [Full Text] [Related]  

  • 11. On the pharmacokinetics of cephalosporin antibiotics.
    Andersson KE
    Scand J Infect Dis Suppl; 1978; (13):37-46. PubMed ID: 278145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of ionization on absorption of cephalosporins.
    DeYoung JL; Tan HG; Huber HE; Zoglio MA
    J Pharm Sci; 1978 Mar; 67(3):320-3. PubMed ID: 25323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GI absorption of beta-lactam antibiotics. III: Kinetic evidence for in situ absorption of ionized species of monobasic penicillins and cefazolin from the rat small intestine and structure-absorption rate relationships.
    Tsuji A; Miyamoto E; Kubo O; Yamana T
    J Pharm Sci; 1979 Jul; 68(7):812-6. PubMed ID: 37320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of cephalosporin antibiotics: protein-binding considerations.
    Singhvi SM; Heald AF; Schreiber EC
    Chemotherapy; 1978; 24(3):121-33. PubMed ID: 657874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative pharmacology of cefaclor and cephalexin.
    Korzeniowski OM; Scheld WM; Sande MA
    Antimicrob Agents Chemother; 1977 Aug; 12(2):157-62. PubMed ID: 900915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between epithelial cell permeability of cephalexin and expression of intestinal oligopeptide transporter.
    Chu XY; Sánchez-Castaño GP; Higaki K; Oh DM; Hsu CP; Amidon GL
    J Pharmacol Exp Ther; 2001 Nov; 299(2):575-82. PubMed ID: 11602669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of protein binding on the disposition of cephalexin and cefazolin in a simultaneous perfusion system of rat liver and kidney.
    Okumura K; Katayama H; Yasuhara M; Hori R
    Chem Pharm Bull (Tokyo); 1989 Nov; 37(11):3150-2. PubMed ID: 2632065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cefazolin and cephalexin kinetics in continuous ambulatory peritoneal dialysis.
    Bunke CM; Aronoff GR; Brier ME; Sloan RS; Luft FC
    Clin Pharmacol Ther; 1983 Jan; 33(1):66-72. PubMed ID: 6848301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Studies on the shift of cefmetazole into the gastrointestinal tract (author's transl)].
    Minamitani M; Hayashi H; Tohma T; Kojima T; Sahashi Y; Terao T
    Jpn J Antibiot; 1980 Jan; 33(1):10-7. PubMed ID: 6929355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative study of cephalexin and cephradine distribution in the body of rats].
    Klimova VS
    Antibiotiki; 1979 Oct; 24(10):764-7. PubMed ID: 496419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.